Ann Oncol 2017; 28: 761–768 (doi: 10.1093/annonc/mdw695)
In the original article, the following funding information was omitted:
This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.
This has now been added.
. 2018 Jan 2;29(7):1607. doi: 10.1093/annonc/mdx802
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab
S M Swain
, A Schneeweiss
, L Gianni
, J J Gao
, A Stein
, M Waldron-Lynch
, S Heeson
, M S Beattie
, B Yoo
, J Cortes
, J Baselga
S M Swain
Find articles by S M Swain
A Schneeweiss
Find articles by A Schneeweiss
L Gianni
Find articles by L Gianni
J J Gao
Find articles by J J Gao
A Stein
Find articles by A Stein
M Waldron-Lynch
Find articles by M Waldron-Lynch
S Heeson
Find articles by S Heeson
M S Beattie
Find articles by M S Beattie
B Yoo
Find articles by B Yoo
J Cortes
Find articles by J Cortes
J Baselga
Find articles by J Baselga
Issue date 2018 Jul.
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
PMCID: PMC6888024 PMID: 29300831
This corrects the article "Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab" in volume 28 on page 761.